JLL: Time Not Right To Sell Patheon

Bookmark and Share

Reuters -- JLL Partners is not in talks to sell its majority stake in Canadian drugmaker Patheon to Switzerland’s Lonza (LONN.VX: Quote), a JLL partner said on Monday, saying it was the wrong time to cash out.

MORE ON THIS TOPIC